Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Vaccine|March 27, 2013
Opinion on adventitious agents testing for vaccines: why do we worry so much about adventitious agents in vaccines?Rebecca L SheetsBiologicals : Journal of the International Association of Biological Standardization|January 7, 2016
Scientific and regulatory challenges in evaluating clinical trial protocols for HIV-1/AIDS vaccines - A review from a regulatory perspectiveRebecca L Sheets, TieQun Zhou, Ivana KnezevicBiologicals : Journal of the International Association of Biological Standardization|January 19, 2016
Review of efficacy trials of HIV-1/AIDS vaccines and regulatory lessons learned: A review from a regulatory perspectiveRebecca L Sheets, TieQun Zhou, Ivana KnezevicBiologicals : Journal of the International Association of Biological Standardization|November 28, 2015
Human challenge trials in vaccine development: Strasbourg, September 29 - October 1, 2014Rebecca L Sheets, Bernard Fritzell, M Teresa Aguado de RosEmerging Microbes & Infections|January 10, 2022
WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20-22 April 2021Margaret A Liu, Tiequn Zhou, Rebecca L Sheets, et al.Biologicals : Journal of the International Association of Biological Standardization|October 18, 2011
Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological productsCarol Marcus-Sekura, James C Richardson, Rebecca K Harston, et al.Vaccine|February 21, 2015
Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: what are the "cGMP"?Rebecca L Sheets, Vijaya Rangavajhula, Jeffrey K Pullen, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|March 30, 2006
Toxicological safety evaluation of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar despite differing plasmid backbones or gene-insertsRebecca L Sheets, Judith Stein, T Scott Manetz, et al.Clinical Microbiology Reviews|July 21, 2022
Controlled Human Infection Models To Accelerate Vaccine DevelopmentRobert K M Choy, A Louis Bourgeois, Christian F Ockenhouse, et al.Current HIV/AIDS Reports|March 9, 2006
Current advances and challenges in HIV-1 vaccinesIsaac R Rodriguez-Chavez, Mary Allen, Edgar L Hill, et al.Pageof 2